Live news related to SANOFI stock (FR0000120578): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Sanofi shares fell by 0.92% to €73.06 in mid-afternoon trading. During the session, the stock touched €72.78, a new low since the 2020 Covid-19 crash …
On Tuesday, Sanofi shares recorded a new six-year low during the session, dropping to €74.21, a level not seen since the Covid-19 crash of 2020. By mi…
Sanofi's stock declines in early afternoon, affected by a downgrade issued on the same day by Morgan Stanley. The movement occurs in a Parisian market…
Sanofi announced on Friday the successful placement of a €2.3 billion bond issue in three tranches, as part of its Euro Medium Term Note program. The …
The Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion recommending the approval of Cenrifk…
Sanofi made significant gains this Thursday, driven by the release of its first quarter 2026 results and favorable news surrounding its flagship produ…
Sanofi reports a strong first quarter of 2026 with a 13.6% increase in revenue at constant exchange rates, driven by pharmaceutical launches and recen…
The United States Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for treating chronic spontaneous urticaria in children aged two…
Sanofi announced that the American Food and Drug Administration has extended the review period for its approval application for Sarclisa in a subcutan…
The European Commission has approved Dupixent (dupilumab) for the treatment of moderate to severe spontaneous chronic urticaria in children aged two t…
